CTEC Convatec Group PLC

LSE · GB · Healthcare · Medical Instruments & Supplies · convatecgroup.com

221.44GBp+1.58%Mkt Cap: 4.54B $P/E: 43.60Today

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company of…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap4.54B USD

Enterprise Value6.39B USD

Revenue (TTM)2.71B USD

Gross Profit1.49B USD

Net Income (TTM)190.22M USD

Revenue/Share1.26 GBp

Last Price221.44 GBp

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees10.0K

CountryGB

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)43.60

P/E (Forward)12.51

PEG0.53

EV/EBITDA10.10

EV/Revenue2.36

P/S1.67

P/B3.92

EPS (TTM)0.05

EPS (Forward)0.17

52W Range

0.000085% of range259.30

52W High259.30 GBp

52W Low0.0000 GBp

Profitability

Gross Margin56.21%

Oper. Margin14.45%

EBITDA Margin23.36%

Profit Margin7.18%

ROE11.53%

ROA4.63%

Growth

Revenue Growth4.40%

Earnings Growth-47.10%

Cash Flow & Leverage

Operating CF510.87M USD

CapEx (TTM)201.09M USD

FCF Margin7.34%

FCF Yield4.37%

Net Debt1.79B USD

Net Debt/EBITDA2.83

Balance Sheet

Debt/Equity1.00

Current Ratio1.93

Quick Ratio1.06

Book Value/Sh0.55 GBp

Cash/Share0.05 GBp

Dividends

Fwd Div Rate0.06 GBp

Trail. Div Rate0.07 GBp

Div. Yield2.56%

5Y Avg Yield2.12%

Payout Ratio116.49%

Ex-Div DateAug 20, 2026

Pay Date—

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)305.39 GBp

Upside (mean)+37.9%

Target Range230.33 GBp – 374.69 GBp

230.33+37.9% to mean374.69

# Analysts19

Ownership

Shares Out.1.92B

Float1.95B

Insiders0.20%

Institutions86.06%

Technical

SMA 50224.02 (-1.1%)

SMA 200222.88 (-0.6%)

Beta0.77

S&P 52W Chg14.58%

Avg Vol (30d)6.88M

Avg Vol (10d)6.38M

Technical Indicators

RSI (14)49.3

MACD-1.9697

MACD Signal-2.4916

MACD Hist.+0.5219

BB Upper223.70 GBp

BB Middle216.45 GBp

BB Lower209.20 GBp

BB Width6.69%

ATR (14)5.092 GBp

Vol Ratio (20d)1.11x